We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$243M
AUM Growth
-$8.83M
Cap. Flow
-$21M
Cap. Flow %
-8.67%
Top 10 Hldgs %
68.56%
Holding
127
New
18
Increased
18
Reduced
12
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 55.53%
2 Technology 8.11%
3 Industrials 7.13%
4 Financials 7.01%
5 Energy 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFC
51
DELISTED
Entegra Financial Corp.
ENFC
$618K 0.25%
21,315
-18,935
-47% -$540K
EIGR
52
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$609K 0.25%
2,062
+1,329
+181% +$393K
KO icon
53
Coca-Cola
KO
$386B
$582K 0.24%
13,400
XENE icon
54
Xenon Pharmaceuticals
XENE
$5.81B
$563K 0.23%
114,900
+20,900
+22% +$77.3K
KHC icon
55
Kraft Heinz
KHC
$30.5B
$554K 0.23%
8,900
-7,000
-44% -$501K
EW icon
56
Edwards Lifesciences
EW
$52B
$543K 0.22%
11,673
-3,000
-20% -$130K
CDOR
57
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$500K 0.21%
50,000
CHEKW
58
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$495K 0.2%
66,059
WHLRD
59
Wheeler Real Estate Investment Trust Series D Preferred Stock
WHLRD
$64.9M
$469K 0.19%
30,000
CHRS icon
60
Coherus Oncology
CHRS
$218M
$446K 0.18%
40,320
+2,000
+5% +$21.9K
BLCM
61
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$444K 0.18%
6,765
+767
+13% +$57.9K
SGYP
62
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$412K 0.17%
225,400
+24,000
+12% +$50.7K
VIVE
63
DELISTED
VIVEVE MED INC
VIVE
$402K 0.17%
110
+10
+10% +$43.5K
GE icon
64
GE Aerospace
GE
$355B
$387K 0.16%
5,984
-1,044
-15% -$77.4K
NVLN
65
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$382K 0.16%
109,184
WPC icon
66
W.P. Carey
WPC
$16.1B
$372K 0.15%
613
-5,513
-90% -$339K
CAG icon
67
Conagra Brands
CAG
$7.72B
$369K 0.15%
10,000
TTE icon
68
TotalEnergies
TTE
$191B
$303K 0.12%
5,260
ANCB
69
DELISTED
Anchor Bancorp
ANCB
$303K 0.12%
12,250
BDSI
70
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$270K 0.11%
+120,000
New +$281K
ALIM
71
DELISTED
Alimera Sciences
ALIM
$235K 0.1%
15,200
+1,667
+12% +$29.6K
CSFL
72
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$184K 0.08%
+6,942
New +$186K
GM icon
73
General Motors
GM
$75.7B
$182K 0.08%
+5,000
New +$203K
ONCT
74
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$178K 0.07%
+71
New +$158K
TST
75
DELISTED
TheStreet, Inc.
TST
$162K 0.07%
9,060
-1,000
-10% -$14.5K

Similar funds

David M. Knott's Q1 2018 Portfolio in Review

As of Q1 2018, David M. Knott held 127 positions worth $243M, down 3.5% from $251M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

David M. Knott withdrew a net $21M in Q1 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Ignyta, Inc., an estimated $1.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.

Against the trend, David M. Knott opened a new position in Calumet Specialty Products worth $6.67M.

  • David M. Knott's largest Q1 2018 buy was Calumet Specialty Products: 945,558 shares worth $6.67M.
  • David M. Knott added most to FTAI Aviation in Q1 2018, an estimated $4.2M increase.
  • David M. Knott's biggest Q1 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $33.3M.
  • David M. Knott fully exited Ignyta, Inc. in Q1 2018, selling an estimated $1.81M.
  • David M. Knott's ten largest holdings make up 69% of its $243M portfolio in Q1 2018.
  • David M. Knott opened 18 new positions and closed 20 in Q1 2018.
  • David M. Knott's portfolio value fell 3.5% quarter-over-quarter to $243M.

Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.